ScienceDex / Researcher record
Gao, Wenda
- Antagen Pharmaceuticals, Inc. (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2011 | $150,000 | 1 | #34,840 |
| 2018 | $599,997 | 1 | #15,120 |
| 2019 | $599,914 | 1 | #16,250 |
| 2022 | $599,998 | 2 | #19,339 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20111 record
- FY20181 record
- FY20191 record
- FY2022 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Gao, Wenda as a PI. Multi-PI records show the full award amount for context.
- 75N93022C00020-0-9999-1N43Contact PIDevelopment of Monoclonal Antibody-mediated Interventions to Combat Malaria$300Kaward amount
- 75N93022C00011-0-9999-1N43Contact PIFcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines$300Kaward amount
Award organization
Organizations that administered FY2022 awards listing Gao, Wenda as a PI.
FY2022 award administered by Antagen Pharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardAntagen Pharmaceuticals, Inc.
- 2018$500K Cumulative Funding
- 2019$1M Cumulative Funding